Civil Litigation
Aug. 1, 2022
States deal with Allergan follows Teva for total $6.62B
The companies are in negotiations led by 13 states. Teva and Allergan still need to reach agreements on business practice changes and transparency requirements. Allergan’s fund will be disbursed over six years while Teva’s will be over 13 years. After they are finalized, the settlements will resolve claims for over 3,000 cases.
Attorney General Rob Bonta, along with a bipartisan group of state attorneys, announced Friday a $2.37 billion settlement with former opioid manufacturer Allergan. On Tuesday, a similar $4.25 billion settlement with another opioid manufacturer, Teva Pharmaceuticals Industries Ltd., was made public.
Under the terms of the tentative agreements, the money would be directed to participating states and municipalities to help tackle the opioid e...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In